N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺
Mirdametinib (PD0325901)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
10 mg 50 mg 100 mg
Product Availability
In-stock
Price
$118.00
Member price
Product Availability
In-stock
Price
$226.00
Member price
Product Availability
In-stock
Price
$336.00
Member price
Quantity
- +
Product Overview
Product Name Mirdametinib (PD0325901)
CAS391210-10-9
FormulaC16H14F3IN2O4
MW482.19
AppearanceWhite powder
Storage condition Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Mirdametinib, also known as PD-0325901, is a potent bioavailable and selective MEK inhibitor, which targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. MEK inhibitor PD325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors.

Related literature
Related
Sorry, no related items
History
Mirdametinib (PD0325901)
Ursodeoxycholic acid(UDCA);Ursodiol;3,7-Dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid
Azeliragon (TTP488)
Veratramine (Synonyms: NSC17821; NSC23880; NSC 17821; NSC 23880)
PNU-159682 (Synonyms: PNU 159682)
Tuvirumab
Otilimab (Synonyms: GSK 3196165; MOR103)
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))
Clazakizumab (Anti-IL-6 / IFNb2)
Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)